Recent clinical advances in lung cancer management

David H. Johnson; Joan H. Schiller; Paul A. Bunn

doi:10.1200/JCO.2013.53.1228

Recent clinical advances in lung cancer management

David H. Johnson, Joan H. Schiller, Paul A. Bunn

Research output: Contribution to journal › Review article › peer-review

173 Scopus citations

Abstract

Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.

Original language	English (US)
Pages (from-to)	973-982
Number of pages	10
Journal	Journal of Clinical Oncology
Volume	32
Issue number	10
DOIs	https://doi.org/10.1200/JCO.2013.53.1228
State	Published - Apr 1 2014

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2013.53.1228

Cite this

@article{cad1fc51cf28435ba599c1b8336ed434,

title = "Recent clinical advances in lung cancer management",

abstract = "Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.",

author = "Johnson, {David H.} and Schiller, {Joan H.} and Bunn, {Paul A.}",

year = "2014",

month = apr,

day = "1",

doi = "10.1200/JCO.2013.53.1228",

language = "English (US)",

volume = "32",

pages = "973--982",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "10",

}

TY - JOUR

T1 - Recent clinical advances in lung cancer management

AU - Johnson, David H.

AU - Schiller, Joan H.

AU - Bunn, Paul A.

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.

AB - Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.

UR - http://www.scopus.com/inward/record.url?scp=84901604030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901604030&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.53.1228

DO - 10.1200/JCO.2013.53.1228

M3 - Review article

C2 - 24567433

AN - SCOPUS:84901604030

VL - 32

SP - 973

EP - 982

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 10

ER -

Recent clinical advances in lung cancer management

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this